AzTrials
AzTrials

Apraxia of SpeechNCT02094014

Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech

An observational study of Apraxia of Speech and Aphasia, run by University of North Carolina, Chapel Hill at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive response, enabling… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Normal Auditory Feedback, Masked Auditory Feedback and Altered Auditory Feedback
How many people
46 participants
Where
1 siteUnited States
Study dates
Mar 2014to Dec 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants with aphasia (PWA) will be referred from existing referral sources (e.g. UNC Stroke registry, Triangle Aphasia Project), clinicians in the community, and the Carolina Data Warehouse for Health.

Who may be able to join

  • Single left-hemisphere cerebrovascular accident
  • Speech errors are present, but participant is able to produce approximations of words or sentences by reading or repetition; < 90% and > 10% on Chapel Hill Multilingual Intelligibility Test (Haley, 2011)
  • Right-handed prior to stroke by report
  • Normal visual attention, acuity, and color vision
  • Pure-tone threshold <= 40 decibels in at least one ear
  • Matched in age and sex to a participant with aphasia
Show all 10Show fewer
  • score of 90% or higher on the single-word intelligibility test
  • Right-handed prior to stroke by report
  • Normal visual attention, acuity, and color vision
  • Pure-tone threshold <= 40 decibels in at least one ear

Who cannot join

  • Predominating disorders of cognition or hearing (e.g. dementia, hearing impairment).
  • Presence of degenerative neurological illness (e.g. Parkinson's disease, amyotrophic lateral sclerosis, primary progressive aphasia).
  • History of stroke
  • History of developmental speech or language disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of North Carolina School of Medicine

    Chapel Hill, North Carolina, 27599-7190

Other trials in United States

About this study

Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive response, enabling future work to develop auditory masking as a treatment adjuvant targeting long-term improvement in speech. Providing an additional treatment option for adults with aphasia and apraxia of speech will have the clear benefit of improving quality of life and allowing individuals to participate more actively in their health care decisions through improved communication.

Read the detailed description

The objective of this research is to test the short-term effects of listening to noise (i.e. auditory feedback masking) on speech fluency in stroke survivors with aphasia and apraxia of speech. People with nonfluent types of aphasia frequently have apraxia of speech, which affects the motor programming of speech movements, causing distortions, slow rate, and speech disfluencies that impede the forward flow of communication. Speaking while listening to noise (e.g. auditory masking) is known to reduce disfluencies and increase speech rate in people who stutter. This method has been tested in people with aphasia, resulting in positive effects on speech production for a subset of those tested. The investigators contend that individuals who have apraxia of speech in addition to aphasia are most likely to benefit from auditory masking, but most previous studies did not test participants for apraxia of speech. In addition, though masking is most likely to affect speech disfluencies, previous studies did not measures disfluencies. The proposed work has two specific aims. Aim 1 will determine the short-term effect of auditory masking, provided on a single day, on speech fluency in stroke survivors with aphasia and apraxia of speech. Aim 2 will identify individual factors that predict a positive response, including presence of apraxia of speech, lesion characteristics, and type of aphasia (e.g. Broca's, Wernicke's). Voxel-based lesion analysis techniques will be used to determine sites of lesion associated with positive and negative response to auditory masking. Completion of this study will remove barriers to studying auditory masking as a technique for clinical intervention, but also as a research tool for behavioral neuroscientists probing the speech motor control system in speakers with aphasia and apraxia of speech.

Being tested
Normal Auditory Feedback, Masked Auditory Feedback, Altered Auditory Feedback
Keywords
Perceptual masking, Auditory stimulation, Speech, Language, Verbal Fluency Disorders
Medical subject headings
Apraxias, Aphasia, Stroke, Speech, Language, Speech Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Normal Auditory FeedbackBehavioural

    Participants will produce sentences under normal speaking conditions, able to hear their own speech.

  • Masked Auditory FeedbackBehavioural

    Also called Masking Noise

    Participants will produce sentences while listening to speech-shaped noise at 85 decibels (sound pressure level) to mask ability to hear their own speech.

  • Altered Auditory FeedbackBehavioural

    Also called Delayed and pitch-shifted feedback

    Participants will produce sentences while listening to their speech shifted up one octave and delayed.

Study groups in NCT02094014
Study groupRoleWhat they receive
Aphasic/Apraxic ParticipantsThe aphasic/apraxic participant group will include 30 adults who have had strokes affecting their ability to communicate verbally, broadly classified as aphasic and including individuals with and without apraxia of speech (AOS). Participants will speak under Masked Auditory Feedback, Altered Auditory Feedback, and Normal Auditory Feedback.
Receives: Behavioral: Normal Auditory Feedback; Behavioral: Masked Auditory Feedback; Behavioral: Altered Auditory Feedback
Neurologically Healthy ParticipantsThe neurologically healthy participant group will include 15 adults with no history of stroke or developmental speech or language disorder. Participants will speak under Masked Auditory Feedback, Altered Auditory Feedback, and Normal Auditory Feedback.
Receives: Behavioral: Normal Auditory Feedback; Behavioral: Masked Auditory Feedback; Behavioral: Altered Auditory Feedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Disfluency duration change with masking noise

    Measured disfluency duration in sentences produced while listening to masking noise compared to speaking in quiet without noise.

    Measured: 1 day of the study

Secondary outcomes (2)
  1. Speech rate change with masking noise

    Measured syllables per second in sentences produced while listening to masking noise compared to speaking in quiet without noise.

    Measured: 1 day of the study

  2. Speech sound accuracy change with masking noise

    Measured speech sound accuracy in sentences produced while listening to masking noise compared to speaking in quiet without noise.

    Measured: 1 day of the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02094014
Sponsor's protocol ID
10-0503
Other IDs
R03DC011881
Status last verified
May 2016
First submitted
13 Mar 2014
Last updated
12 May 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Apraxia of Speech and Aphasia, run by University of North Carolina, Chapel Hill at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Disfluency duration change with masking noise (time frame: 1 day of the study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in